Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
THBS2
REST API REST API
Homo sapiens
THBS2 is differentially expressed in 212 experiments: 159 organism parts: liver, skin, ... (157 more);, 177 disease states: normal, lung adenocarcinoma, ... (175 more);, 83 cell types 252 cell lines 16 compound treatments and 55 other conditions.
Synonyms TSP2
Orthologs Thbs2 (Rattus norvegicus)   Q28195_BOVIN (Bos taurus)   Q5VH52_CIOIN (Ciona intestinalis)   thbs2a (Danio rerio)   THBS2 (Gallus gallus)   thbs2b (Danio rerio)   Tsp (Drosophila melanogaster)   Thbs2 (Mus musculus)   thbs2 (Xenopus laevis)   thbs2a (Danio rerio)   THBS2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, heparin binding, structural molecule activity, extracellular region, basement membrane, cell adhesion, extracellular matrix, calcium ion binding, negative regulation of angiogenesis, positive regulation of synapse assembly
InterPro Term VWF_C, EGF, Laminin_G_thrombospondin_N, Thrombospondin_3-like_rpt, EGF_3, Thrombospondin_C, Thrombospondin_1_rpt, EGF-like, EGF-like_Ca-bd
UniProt Accession Q5RI53, P35442, Q6MZL6
Gene-Disease Assocation INTERVERTEBRAL DISC DISEASE; IDD
Search EB-eye ENSG00000186340
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-803, E-GEOD-22541, E-GEOD-6573, E-GEOD-1577, ... (27 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-19639, E-GEOD-4717, E-MTAB-62, E-GEOD-21570, ... (28 experiments)

Factor Value U/D Experiments
HT1080
2
E-MTAB-37, E-GEOD-20089
SW480
2
E-MEXP-1014, E-MTAB-37
ANBL-6
1
E-MEXP-921
SW780
1
E-MTAB-37
CGTHW1
1
E-MTAB-37
A673
1
E-MTAB-37
246 more value(s).


Cell type

studied in E-GEOD-492, E-GEOD-21668, E-GEOD-3920, E-MEXP-66, E-GEOD-13987, ... (38 experiments)

Factor Value U/D Experiments
2
E-TABM-145, E-TABM-130
embryonic stem cell
2
E-MEXP-930, E-GEOD-2248
stromal cell
2
3
E-GEOD-1460, E-GEOD-3998, E-MEXP-1327, E-GEOD-10797, E-MEXP-2034 ... (5 experiments)
adipocyte
1
2
E-AFMX-5, E-MTAB-25, E-TABM-145
fibroblast
1
2
E-GEOD-3920, E-GEOD-3204, E-MEXP-466
germ cell
1
E-MTAB-25
77 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-GEOD-1577, E-MEXP-1121, E-TABM-15, ... (54 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
4
E-GEOD-2514, E-MTAB-37, E-MEXP-231, E-MTAB-62
prostate carcinoma
4
E-GEOD-96, E-MEXP-2034, E-GEOD-7307, E-MTAB-62
colon carcinoma
3
E-MTAB-37, E-MTAB-62, E-GEOD-3726
uterine fibroid
3
E-MTAB-62, E-GEOD-7307, E-GEOD-2724
lung carcinoma
2
E-GEOD-6014, E-MTAB-37
acute promyelocytic leukemia
2
E-GEOD-96, E-MTAB-62
171 more value(s).


Compound treatment

studied in E-MEXP-1269, E-GEOD-15205, E-GEOD-6932, E-GEOD-412, E-GEOD-7216, ... (9 experiments)

Factor Value U/D Experiments
interleukin-19 (Homo sapiens)
1
E-GEOD-7216
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
keratinocyte growth factor
1
E-GEOD-7216
2-(3,4,5-trimethoxy-phenylamino)-pyrrolo[2,3-d]pyrimidines
1
E-GEOD-6932
Cxcl12
1
E-GEOD-7307
TGF
1
E-GEOD-15205
10 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-GEOD-22513, ... (11 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-19018, E-GEOD-20033, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-GEOD-22541, E-TABM-147, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-7578, E-GEOD-20847, E-MTAB-108, E-GEOD-361, ... (6 experiments)

Genotype
studied in E-GEOD-3494, E-TABM-36, E-GEOD-2466, E-GEOD-17476, E-GEOD-2292, ... (9 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-20540, E-MEXP-1446, E-GEOD-9764, E-GEOD-10315, ... (7 experiments)

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-GEOD-19330, E-GEOD-19519, ... (20 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-GEOD-9723

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Light
studied in E-GEOD-1725

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-GEOD-426

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-21750, E-GEOD-2487

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-10797

RNAi
studied in E-GEOD-1676, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-2466, E-GEOD-7307

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-16837, E-GEOD-19246

Tumor grading
studied in E-GEOD-22541, E-TABM-147

Processing time: 0.433 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM